Literature DB >> 16678698

Temporal changes in mouse aortic wall gene expression during the development of elastase-induced abdominal aortic aneurysms.

Sarah J Van Vickle-Chavez1, William S Tung, Tarek S Absi, Terri L Ennis, Dongli Mao, J Perren Cobb, Robert W Thompson.   

Abstract

OBJECTIVE: To characterize temporal changes in mouse aortic wall gene expression associated with the development of experimental abdominal aortic aneurysms.
METHODS: C57BL/6 mice underwent transient perfusion of the abdominal aorta with either elastase (n = 61) or heat-inactivated elastase as a control (n = 68). Triplicate samples of radiolabeled aortic wall complementary DNA were prepared at intervals of 0, 3, 7, 10, and 14 days, followed by hybridization to nylon microarrays (1181 genes). Autoradiographic intensity data were normalized by conversion to z scores, and differences in gene expression were defined by two-tailed z tests at a significance threshold of P < .01.
RESULTS: Elastase perfusion caused a progressive increase in aortic diameter up to 14 days accompanied by transmural inflammation and destructive remodeling of the elastic media. No aneurysms occurred in the control group. Compared with healthy aorta, 336 genes exhibited significant alterations during at least 1 interval after elastase perfusion (135 at more than 1 interval and 14 at all intervals), with pronounced increases for interleukin 6, cyclin E2, interleukin 1beta, osteopontin, CD14/lipopolysaccharide receptor, P-selectin glycoprotein ligand 1, and gelatinase B/matrix metalloproteinase 9 (all >20-fold on day 3). Sixty-two genes exhibited synchronous alterations in the elastase and control groups, thus suggesting a nonspecific response. By direct comparisons between the elastase and control groups, there were 384 genes with significant differences in expression for at least 1 interval after aortic perfusion, including 234 with differential upregulation (eg, p44MAPK/ERK1, osteopontin, heat shock protein 84, hypoxia-inducible factor 1alpha, apolipoprotein E, monocyte chemotactic protein 3, MIG (monokine induced by gamma interferon), and interleukin 2 receptor gamma) and 163 with differential downregulation (eg, prothrombin, granzyme B, ataxia telangiectasia mutated, and interleukin-converting enzyme).
CONCLUSIONS: Development of elastase-induced abdominal aortic aneurysms in mice is accompanied by altered aortic wall expression of genes associated with acute and chronic inflammation, matrix degradation, and vascular tissue remodeling. Knowledge of these alterations will facilitate further studies on the functional molecular mechanisms that underlie aneurysmal degeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678698     DOI: 10.1016/j.jvs.2006.01.004

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  24 in total

1.  Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms.

Authors:  Craig J Goergen; Junya Azuma; Kyla N Barr; Lars Magdefessel; Dara Y Kallop; Alvin Gogineni; Amarjeet Grewall; Robby M Weimer; Andrew J Connolly; Ronald L Dalman; Charles A Taylor; Philip S Tsao; Joan M Greve
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

2.  Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice.

Authors:  Johannes Stegbauer; Sean E Thatcher; Guang Yang; Katharina Bottermann; Lars Christian Rump; Alan Daugherty; Lisa A Cassis
Journal:  J Vasc Surg       Date:  2019-03-06       Impact factor: 4.268

3.  Circulating interferon-γ-inducible Cys-X-Cys chemokine receptor 3 ligands are elevated in humans with aortic aneurysms and Cys-X-Cys chemokine receptor 3 is necessary for aneurysm formation in mice.

Authors:  Amy Gallo; Ahmad Saad; Rahmat Ali; Alan Dardik; George Tellides; Arnar Geirsson
Journal:  J Thorac Cardiovasc Surg       Date:  2011-09-29       Impact factor: 5.209

4.  Cysteine Protease Cathepsins in Atherosclerosis and Abdominal Aortic Aneurysm.

Authors:  Sara Sjöberg; Guo-Ping Shi
Journal:  Clin Rev Bone Miner Metab       Date:  2011-06-18

5.  Acute mechanical effects of elastase on the infrarenal mouse aorta: implications for models of aneurysms.

Authors:  M J Collins; J F Eberth; E Wilson; J D Humphrey
Journal:  J Biomech       Date:  2012-01-10       Impact factor: 2.712

6.  MicroRNA-26a is a novel regulator of vascular smooth muscle cell function.

Authors:  Nicholas J Leeper; Azad Raiesdana; Yoko Kojima; Hyung J Chun; Junya Azuma; Lars Maegdefessel; Ramendra K Kundu; Thomas Quertermous; Philip S Tsao; Joshua M Spin
Journal:  J Cell Physiol       Date:  2011-04       Impact factor: 6.384

7.  Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.

Authors:  Yasunori Iida; Baohui Xu; Haojun Xuan; Keith J Glover; Hiroki Tanaka; Xiaolei Hu; Naoki Fujimura; Wei Wang; Joshua R Schultz; Court R Turner; Ronald L Dalman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

Review 8.  Gender differences in abdominal aortic aneurysms.

Authors:  Kevin K Hannawa; Jonathan L Eliason; Gilbert R Upchurch
Journal:  Vascular       Date:  2009 May-Jun       Impact factor: 1.285

9.  Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.

Authors:  Wei Wang; Baohui Xu; Haojun Xuan; Yingbin Ge; Yan Wang; Lixin Wang; Jianhua Huang; Weiguo Fu; Sara A Michie; Ronald L Dalman
Journal:  J Vasc Surg       Date:  2017-12-11       Impact factor: 4.268

10.  Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm.

Authors:  Catherine Rush; Moses Nyara; Joseph V Moxon; Alexandra Trollope; Bradford Cullen; Jonathan Golledge
Journal:  BMC Genomics       Date:  2009-07-06       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.